mdlinx mdlinx
Latest (61) Full Text Focus on Dermatologic Article Summary

Racial disparities in Hodgkin's lymphoma: A comprehensive population-based analysis
Annals of Oncology, 01/13/2012

Evens AM et al –The authors identified multiple racial disparities, including survival, in adolescent/adult HL.

Methods

  • Examined time-, age-, and gender-specific incidence, disease characteristics, and survival across and within races for adolescent/adult HL (age 10–79 years) diagnosed during 1992–2007 in the SEER 13 registries

Results

  • 15,662 HL cases were identified [11,211 non-Hispanic whites, 2067 Hispanics, 1662 blacks, and 722 Asian/Pacific Islanders (A/PI)]. Similar to whites, A/PIs had bimodal age-specific incidence, while blacks and Hispanics did not
  • Further, HL was significantly more common in Hispanics versus whites age >65 years (7.0/1 × 106 versus 4.5/1 × 106, respectively, P < 0.01)
  • By place of birth, US-born Hispanics and A/PIs age 20–39 years had higher incidence of HL versus their foreign-born counterparts (P < 0.05), however, rates converged age >40 years
  • Interestingly, from 1992–1997 to 2003–2007, A/PI incidence rates increased >50% (P < 0.001)
  • Moreover, this increase was restricted to US-born A/PI
  • Identified a number of disease-related differences based on race
  • Finally, 5-, 10-, and 15-year OS rates were inferior for blacks and Hispanics compared with whites (P < 0.005 and P < 0.001, respectively) and A/PI (P < 0.018 and P < 0.001, respectively)
  • These differences persisted on multivariate analysis

Read this article in Annals of Oncology read MDLinx article: Racial disparities in Hodgkin's lymphoma: A comprehensive population-based analysis

<< Previous Article | Next Article >>

    Currently, there are no available articles.

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Most Popular Oncology Articles

Last month's top read Top 50 of 2011

1 Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP Protocol B-24 Journal of Clinical Oncology, April 9, 2012    Clinical Article

2 The clinical utility of serum CA 19-9 in the diagnosis, prognosis and management of pancreatic adenocarcinoma: An evidence based appraisal Full Text Journal of Gastrointestinal Oncology, April 16, 2012    Free full text    Clinical Article

3 Preoperative chemotherapy plus trastuzumab, lapatinib, or both in human epidermal growth factor receptor 2-positive operable breast cancer: Results of the randomized phase III CHER-LB study Journal of Clinical Oncology, April 12, 2012    Clinical Article

4 Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer European Journal of Cancer, April 2, 2012    Clinical Article

5 Metformin use is associated with better survival of diabetic patients with pancreatic cancer Clinical Cancer Research, April 4, 2012    Clinical Article

6 Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study The Lancet, April 24, 2012    Clinical Article

7 Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials The Lancet Oncology - Online First, March 22, 2012    Clinical Article

8 Carboplatin- or cisplatin-based chemotherapy in first-line treatment of small-cell lung cancer: the COCIS meta-analysis of individual patient data Journal of Clinical Oncology, April 5, 2012    Clinical Article

9 Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer Cancer, April 6, 2012    Clinical Article

10 Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial The Lancet Oncology - Online First, March 28, 2012    Clinical Article

11 Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial The Lancet - Early Online Publication, April 5, 2012    Clinical Article

12 The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus International Journal of Cancer, April 26, 2012    Clinical Article

13 Infectious complications of chemotherapy in clinically aggressive mature B and T cell lymphomas European Journal of Internal Medicine , April 3, 2012    Clinical Article

14 Carboplatin and paclitaxel with vs without bevacizumab in older patients with advanced non-small cell lung cancer JAMA, April 19, 2012    Clinical Article

15 Association between tamoxifen treatment and diabetes Cancer, April 16, 2012    Clinical Article

16 The utility of serum CA-125 in predicting extra-uterine disease in apparent early-stage endometrial cancer International Journal of Cancer, April 23, 2012    Clinical Article

17 Pneumonitis associated with mTOR inhibitors therapy in patients with metastatic renal cell carcinoma: Incidence, radiographic findings and correlation with clinical outcome European Journal of Cancer, April 11, 2012    Clinical Article

18 Digoxin use and the risk of cancers of the corpus uteri, ovary and cervix International Journal of Cancer, April 18, 2012    Clinical Article

19 Gefitinib versus placebo as maintenance therapy in patients with locally advanced or metastatic non-small-cell lung cancer (INFORM; C-TONG 0804): a multicentre, double-blind randomised phase 3 trial The Lancet Oncology - Online First, April 20, 2012    Clinical Article

20 Multicenter randomized phase II clinical trial comparing neoadjuvant oxaliplatin, capecitabine, and preoperative radiotherapy with or without cetuximab followed by total mesorectal excision in patients with high-risk rectal cancer (EXPERT-C) Journal of Clinical Oncology, April 9, 2012    Clinical Article

Indexed Journals in Oncology: Journal of Clinical Oncology, Cancer Research, Annals Oncologymore

Other Topics in Oncology

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close